BioLife Solutions (BLFS) Competitors $27.39 +1.28 (+4.90%) (As of 12/20/2024 05:15 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends BLFS vs. PRCT, AXNX, NVCR, NVST, NARI, IRTC, LIVN, ENOV, WRBY, and CNMDShould you be buying BioLife Solutions stock or one of its competitors? The main competitors of BioLife Solutions include PROCEPT BioRobotics (PRCT), Axonics (AXNX), NovoCure (NVCR), Envista (NVST), Inari Medical (NARI), iRhythm Technologies (IRTC), LivaNova (LIVN), Enovis (ENOV), Warby Parker (WRBY), and CONMED (CNMD). These companies are all part of the "medical equipment" industry. BioLife Solutions vs. PROCEPT BioRobotics Axonics NovoCure Envista Inari Medical iRhythm Technologies LivaNova Enovis Warby Parker CONMED BioLife Solutions (NASDAQ:BLFS) and PROCEPT BioRobotics (NASDAQ:PRCT) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, community ranking, media sentiment, profitability, dividends, valuation, analyst recommendations and institutional ownership. Does the MarketBeat Community favor BLFS or PRCT? BioLife Solutions received 272 more outperform votes than PROCEPT BioRobotics when rated by MarketBeat users. However, 67.86% of users gave PROCEPT BioRobotics an outperform vote while only 67.39% of users gave BioLife Solutions an outperform vote. CompanyUnderperformOutperformBioLife SolutionsOutperform Votes31067.39% Underperform Votes15032.61% PROCEPT BioRoboticsOutperform Votes3867.86% Underperform Votes1832.14% Do analysts rate BLFS or PRCT? BioLife Solutions currently has a consensus target price of $29.00, indicating a potential upside of 5.88%. PROCEPT BioRobotics has a consensus target price of $97.86, indicating a potential upside of 20.56%. Given PROCEPT BioRobotics' higher probable upside, analysts plainly believe PROCEPT BioRobotics is more favorable than BioLife Solutions.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioLife Solutions 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00PROCEPT BioRobotics 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86 Is BLFS or PRCT more profitable? BioLife Solutions has a net margin of -38.98% compared to PROCEPT BioRobotics' net margin of -50.07%. BioLife Solutions' return on equity of -6.61% beat PROCEPT BioRobotics' return on equity.Company Net Margins Return on Equity Return on Assets BioLife Solutions-38.98% -6.61% -5.54% PROCEPT BioRobotics -50.07%-38.57%-26.06% Do insiders & institutionals believe in BLFS or PRCT? 93.2% of BioLife Solutions shares are held by institutional investors. Comparatively, 89.5% of PROCEPT BioRobotics shares are held by institutional investors. 2.2% of BioLife Solutions shares are held by insiders. Comparatively, 17.4% of PROCEPT BioRobotics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the media prefer BLFS or PRCT? In the previous week, BioLife Solutions had 5 more articles in the media than PROCEPT BioRobotics. MarketBeat recorded 9 mentions for BioLife Solutions and 4 mentions for PROCEPT BioRobotics. PROCEPT BioRobotics' average media sentiment score of 1.35 beat BioLife Solutions' score of 0.45 indicating that PROCEPT BioRobotics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioLife Solutions 4 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral PROCEPT BioRobotics 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher earnings and valuation, BLFS or PRCT? BioLife Solutions has higher earnings, but lower revenue than PROCEPT BioRobotics. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than BioLife Solutions, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioLife Solutions$146.96M8.65-$66.43M-$1.06-25.84PROCEPT BioRobotics$199.84M21.20-$105.90M-$1.95-41.63 Which has more volatility and risk, BLFS or PRCT? BioLife Solutions has a beta of 1.91, meaning that its share price is 91% more volatile than the S&P 500. Comparatively, PROCEPT BioRobotics has a beta of 0.99, meaning that its share price is 1% less volatile than the S&P 500. SummaryBioLife Solutions beats PROCEPT BioRobotics on 12 of the 18 factors compared between the two stocks. Ad Brownstone ResearchMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. Get BioLife Solutions News Delivered to You Automatically Sign up to receive the latest news and ratings for BLFS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BLFS vs. The Competition Export to ExcelMetricBioLife SolutionsElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.27B$3.07B$5.14B$9.08BDividend YieldN/A1.75%5.09%4.23%P/E Ratio-25.8417.1689.9717.18Price / Sales8.6550.221,116.21116.99Price / CashN/A39.9142.8937.86Price / Book3.573.724.784.78Net Income-$66.43M$89.83M$120.23M$225.60M7 Day Performance2.58%-1.76%-1.92%-1.23%1 Month Performance7.88%0.32%11.49%3.36%1 Year Performance73.90%4.12%30.57%16.60% BioLife Solutions Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BLFSBioLife Solutions1.2602 of 5 stars$27.39+4.9%$29.00+5.9%+79.4%$1.27B$146.96M-25.84409Analyst ForecastInsider TradeNews CoverageHigh Trading VolumePRCTPROCEPT BioRobotics2.7595 of 5 stars$89.09-0.2%$97.86+9.8%+102.9%$4.65B$136.19M0.00626Positive NewsAXNXAxonics1.4204 of 5 stars$70.98+0.8%$71.00+0.0%+20.9%$3.63B$366.38M-591.45610High Trading VolumeNVCRNovoCure2.4915 of 5 stars$32.75-2.0%$32.67-0.3%+138.4%$3.54B$577.74M-23.861,453NVSTEnvista3.9074 of 5 stars$19.59+0.6%$20.65+5.4%-21.1%$3.37B$2.50B-2.5112,800Positive NewsNARIInari Medical3.3112 of 5 stars$55.39-0.4%$58.89+6.3%-11.9%$3.24B$574.50M-41.181,300Analyst ForecastInsider TradeIRTCiRhythm Technologies3.0956 of 5 stars$89.50+3.6%$107.82+20.5%-14.3%$2.80B$492.68M-17.782,000Analyst ForecastLIVNLivaNova3.626 of 5 stars$50.15-2.6%$69.17+37.9%-4.4%$2.72B$1.24B122.622,900Analyst UpgradePositive NewsENOVEnovis2.9726 of 5 stars$46.56+0.9%$67.00+43.9%-21.5%$2.60B$2.00B-21.396,550Positive NewsWRBYWarby Parker1.5771 of 5 stars$24.24+2.6%$20.73-14.5%+99.1%$2.46B$669.77M-87.523,491Insider TradeCNMDCONMED4.6139 of 5 stars$71.57-1.4%$79.80+11.5%-36.7%$2.21B$1.29B17.234,000Positive News Related Companies and Tools Related Companies PROCEPT BioRobotics Competitors Axonics Competitors NovoCure Competitors Envista Competitors Inari Medical Competitors iRhythm Technologies Competitors LivaNova Competitors Enovis Competitors Warby Parker Competitors CONMED Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BLFS) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLife Solutions, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLife Solutions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
